2.27
Sab Biotherapeutics Inc (SABS) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
-
|
- | 0.1147 | - | 0.2631 |
|
9.65%
9.7321
|
10.77 | 10.12 | 11.31 | 10.46 |
Operating Income/Loss |
9.65%
-9.7321
|
-10.77 | -10.01 | -11.31 | -10.20 |
Nonoperating Income/Loss |
106.86%
-0.3822
|
5.5753 | -1.3859 | 0.96 | 2.8662 |
Income/Loss From Continuing Operations Before Tax |
94.63%
-10.11
|
-5.1968 | 24.03 | -10.35 | -7.3355 |
Income/Loss From Continuing Operations After Tax |
94.63%
-10.11
|
-5.1968 | -11.39 | -10.35 | -7.3355 |
|
94.63%
-10.11
|
-5.1968 | -11.39 | -10.35 | -7.3355 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.03%
9.2945
|
9.2916 | 0.00982 | 9.2592 | 9.255 |
Diluted Average Shares |
0.03%
9.2945
|
9.2916 | 0.00982 | 9.2592 | 9.255 |
Basic Earnings Per Share |
94.64%
-1.09
|
-0.56 | -1.23 | -1.12 | -0.79 |
Diluted Earnings Per Share |
94.64%
-1.09
|
-0.56 | -1.23 | -1.12 | -0.79 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):